Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).
Services
Services
Date issued
2011Journal title
LEUKEMIA & LYMPHOMA
Type of content
Artigo
